Navigation Links
John Theurer Cancer Center first cancer center in N.J. to acquire new radiotherapy system
Date:7/19/2010

HACKENSACK, NJ July 19, 2010 In a promising development for cancer patients in New Jersey and surrounding areas, the John Theurer Cancer Center at Hackensack University Medical Center announced today that it will be the first cancer center in New Jersey to acquire an innovative system that enables a radically different approach to treating cancer with image-guided radiotherapy (IGRT) known as the TrueBeam system. The new radiotherapy system was delivered on June 26 and will be operational when the new $130-million comprehensive cancer facility opens in January 2011, further enhancing the John Theurer Cancer Center's treatment capabilities.

"TrueBeam is a real game-changer that will enable us to treat even the most challenging cases with unprecedented speed and accuracy," said Anthony Ingenito, M.D., Chairman, Radiation Oncology, the John Theurer Cancer Center. "We are excited to offer our patients radiation treatment that is even more precise for many different forms of cancers."

The TrueBeam system, from Varian Medical Systems, was engineered from the ground up to deliver more powerful cancer treatments with pinpoint accuracy and precision. It uniquely integrates new imaging and motion management technologies within a sophisticated new architecture that makes it possible to deliver treatments faster while monitoring and compensating for tumor motion, opening the door to new possibilities for the treatment of lung, breast, prostate, head and neck, as well as other cancers that are treatable with radiotherapy.

This state-of-the-art radiotherapy system allows the John Theurer Cancer Center to offer even faster treatments, enhanced accuracy, and quicker imaging at lower doses.

  • With dose delivery rates that are 40-140 percent higher than earlier generations of Varian technology, simple treatments that once took 15 minutes or more can be completed in less than two minutes once the patient is in position.
  • "Intelligent" automation further speeds treatments with an up to five-fold reduction in the number of steps needed for image guidance and dose delivery.
  • The precision is measured in increments of less than a millimeter. This accuracy is made possible by the system's sophisticated architecture, which synchronizes imaging, patient positioning, motion management, beam shaping, and dose delivery, performing accuracy checks every ten milliseconds throughout the entire treatment.
  • For lung and other tumors subject to respiratory motion, this system makes it possible to monitor patient breathing and to compensate for tumor motion while quickly delivering a dose during a continuous rotation around the patient.
  • This radiotherapy system will allow physicians to choose an imaging mode that minimizes the amount of X-rays needed to generate an image. The imaging technology can produce the three-dimensional images used to fine-tune tumor targeting in 60 percent less time and the additional functionality makes it possible to create images using 25 percent less X-ray dose.

Acquiring the TrueBeam system to enhance its services is another step in the John Theurer Cancer Center's ongoing commitment to improving radiation oncology treatments through research and offering the latest technological advancements. In addition to adopting TrueBeam, the radiation oncology division is continually active in clinical trials with research in other new approaches such as brachytherapy, Dose Verification System (DVS), and TomoTherapy.

"By integrating new therapies and providing extensive training to our expert staff, the John Theurer Cancer Center is able to deliver unparalleled radiation treatment," said Andrew Pecora, M.D., F.A.C.P., C.P.E., Chairman and Executive Administrative Director, the John Theurer Cancer Center. "Offering innovative treatment options is just one of the many ways we are fulfilling our mission to provide extraordinary patient care."


'/>"/>

Contact: Amy Leahing
amy.leahing@widmeyer.com
646-213-7245
John Theurer Cancer Center
Source:Eurekalert

Related medicine news :

1. John Theurer Cancer Center hosts hematologic malignancies program for physicians and patients
2. John Theurer Cancer Center offers breakthrough radiation measurement technology
3. Leading physicians and researchers at the John Theurer Cancer Center present research at ASCO
4. John Theurer Cancer Center experts present new cancer research at ASCO Annual Meeting
5. The John Theurer Cancer Center recognizes medical physics team for safety track record
6. John Theurer Cancer Center and LLS host panel discussion with leading hematologists
7. Enhancing arrest of cell growth to treat cancer in mice
8. Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer
9. The National Coalition for Cancer Survivorship Joins the Commission on Cancer
10. Low forms of cyclin E reduce breast cancer drugs effectiveness
11. Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2017)... ... ... Center is now offering various types of dental implants to restore lost teeth. Dental implants ... such as crowns, bridges, or dentures. An implant is placed directly into the jawbone where ... tooth. , Several types of dental implants are available, including: , ...
(Date:6/26/2017)... ... June 26, 2017 , ... The Centers for ... the hiring of Richard Robinson as chief operating officer (COO). In this role, ... a proven track record of simplifying business processes and developing growth strategies to ...
(Date:6/26/2017)... ... June 26, 2017 , ... ... leakage is revolutionizing the way women look and feel about themselves and their ... of female sexual dysfunction and urinary leakage head on with a ground breaking ...
(Date:6/26/2017)... , ... June 26, 2017 , ... ... staff, and consumers are seeing lots of red these days. According to recent ... charges that result from medical coding errors(1). Some studies point to Electronic Health ...
(Date:6/26/2017)... ... June 26, 2017 , ... New patients with ... Angela Cotey, with or without a referral. Dr. Cotey is a trusted dentist who ... preferred tooth replacement option. , Patients with missing teeth in Fitchburg, WI, are encouraged ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: